Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction
Abstract Preeclampsia (PE) and fetal growth restriction (FGR) are both placenta-mediated disorders with unclear pathogenesis. Metabolomics of maternal and fetal pairs might help in understanding these disorders. We recruited prospectively pregnancies with normotensive FGR, PE without FGR, PE + FGR a...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d6aaaf41e16a4bf398e8f7ed65b26696 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d6aaaf41e16a4bf398e8f7ed65b26696 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d6aaaf41e16a4bf398e8f7ed65b266962021-12-02T18:30:39ZPaired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction10.1038/s41598-021-93936-92045-2322https://doaj.org/article/d6aaaf41e16a4bf398e8f7ed65b266962021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93936-9https://doaj.org/toc/2045-2322Abstract Preeclampsia (PE) and fetal growth restriction (FGR) are both placenta-mediated disorders with unclear pathogenesis. Metabolomics of maternal and fetal pairs might help in understanding these disorders. We recruited prospectively pregnancies with normotensive FGR, PE without FGR, PE + FGR and uncomplicated pregnancies as controls. Nuclear magnetic resonance metabolomics were applied on plasma samples collected at delivery. Advanced lipoprotein, glycoprotein and choline profiling was performed using the Liposcale test. The software package Dolphin was used to quantify 24 low-molecular-weight metabolites. Statistical analysis comprised the comparison between each group of complicated pregnancies versus controls, considering 5% false discovery rate correction. Lipid profiles were altered in accordance with the clinical presentation of these disorders. Specifically, PE mothers and FGR fetuses (with or without FGR or PE, respectively) exhibited a pro-atherogenic and pro-inflammatory profile, with higher concentrations of triglycerides, remnant cholesterol (VLDL, IDL) and Glc/GalNAc-linked and lipid-associated glycoproteins compared to controls. Low-molecular-weight metabolites were extensively disturbed in preeclamptic mothers, with or without FGR. Growth restricted fetuses in the presence of PE showed changes in low-molecular-weight metabolites similar to their mothers (increased creatine and creatinine), while normotensive FGR fetuses presented scarce differences, consistent with undernutrition (lower isoleucine). Further research is warranted to clarify maternal and fetal adaptations to PE and FGR.Lina YoussefRui V. SimõesJezid MirandaMaría Luisa García-MartínCristina PaulesFrancesca CrovettoNuria AmigóNicolau CañellasEduard GratacosFatima CrispiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Lina Youssef Rui V. Simões Jezid Miranda María Luisa García-Martín Cristina Paules Francesca Crovetto Nuria Amigó Nicolau Cañellas Eduard Gratacos Fatima Crispi Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction |
description |
Abstract Preeclampsia (PE) and fetal growth restriction (FGR) are both placenta-mediated disorders with unclear pathogenesis. Metabolomics of maternal and fetal pairs might help in understanding these disorders. We recruited prospectively pregnancies with normotensive FGR, PE without FGR, PE + FGR and uncomplicated pregnancies as controls. Nuclear magnetic resonance metabolomics were applied on plasma samples collected at delivery. Advanced lipoprotein, glycoprotein and choline profiling was performed using the Liposcale test. The software package Dolphin was used to quantify 24 low-molecular-weight metabolites. Statistical analysis comprised the comparison between each group of complicated pregnancies versus controls, considering 5% false discovery rate correction. Lipid profiles were altered in accordance with the clinical presentation of these disorders. Specifically, PE mothers and FGR fetuses (with or without FGR or PE, respectively) exhibited a pro-atherogenic and pro-inflammatory profile, with higher concentrations of triglycerides, remnant cholesterol (VLDL, IDL) and Glc/GalNAc-linked and lipid-associated glycoproteins compared to controls. Low-molecular-weight metabolites were extensively disturbed in preeclamptic mothers, with or without FGR. Growth restricted fetuses in the presence of PE showed changes in low-molecular-weight metabolites similar to their mothers (increased creatine and creatinine), while normotensive FGR fetuses presented scarce differences, consistent with undernutrition (lower isoleucine). Further research is warranted to clarify maternal and fetal adaptations to PE and FGR. |
format |
article |
author |
Lina Youssef Rui V. Simões Jezid Miranda María Luisa García-Martín Cristina Paules Francesca Crovetto Nuria Amigó Nicolau Cañellas Eduard Gratacos Fatima Crispi |
author_facet |
Lina Youssef Rui V. Simões Jezid Miranda María Luisa García-Martín Cristina Paules Francesca Crovetto Nuria Amigó Nicolau Cañellas Eduard Gratacos Fatima Crispi |
author_sort |
Lina Youssef |
title |
Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction |
title_short |
Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction |
title_full |
Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction |
title_fullStr |
Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction |
title_full_unstemmed |
Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction |
title_sort |
paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/d6aaaf41e16a4bf398e8f7ed65b26696 |
work_keys_str_mv |
AT linayoussef pairedmaternalandfetalmetabolomicsrevealadifferentialfingerprintinpreeclampsiaversusfetalgrowthrestriction AT ruivsimoes pairedmaternalandfetalmetabolomicsrevealadifferentialfingerprintinpreeclampsiaversusfetalgrowthrestriction AT jezidmiranda pairedmaternalandfetalmetabolomicsrevealadifferentialfingerprintinpreeclampsiaversusfetalgrowthrestriction AT marialuisagarciamartin pairedmaternalandfetalmetabolomicsrevealadifferentialfingerprintinpreeclampsiaversusfetalgrowthrestriction AT cristinapaules pairedmaternalandfetalmetabolomicsrevealadifferentialfingerprintinpreeclampsiaversusfetalgrowthrestriction AT francescacrovetto pairedmaternalandfetalmetabolomicsrevealadifferentialfingerprintinpreeclampsiaversusfetalgrowthrestriction AT nuriaamigo pairedmaternalandfetalmetabolomicsrevealadifferentialfingerprintinpreeclampsiaversusfetalgrowthrestriction AT nicolaucanellas pairedmaternalandfetalmetabolomicsrevealadifferentialfingerprintinpreeclampsiaversusfetalgrowthrestriction AT eduardgratacos pairedmaternalandfetalmetabolomicsrevealadifferentialfingerprintinpreeclampsiaversusfetalgrowthrestriction AT fatimacrispi pairedmaternalandfetalmetabolomicsrevealadifferentialfingerprintinpreeclampsiaversusfetalgrowthrestriction |
_version_ |
1718378008505483264 |